REVIEW

How to prevent steroid induced osteoporosis

P N Sambrook

Correspondence to:
Correspondence to:
Professor P N Sambrook
Royal North Shore Hospital, St Leonards, Sydney, Australia 2065; sambrook{at}med.usyd.ed.au

The first choice for prevention of corticosteroid osteoporosis is a potent oral bisphosphonate—for example, alendronate or risedronate. Intravenous bisphosphonates should be considered for patients intolerant of the oral route. For patients receiving chronic low dose corticosteroids treatment with calcium and vitamin D may prevent further bone loss. Use of parathyroid hormone is promising.

Abbreviations: BMD, bone mineral density; CS, corticosteroid(s); HT, hormone therapy; PTH, parathyroid hormone

Keywords: bisphosphonates; glucocorticoids; osteoporosis; vitamin D

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• STOCH, S. A., SAAG, K. G., GREENWALD, M., SEBBA, A. I., COHEN, S., VERBRUGGEN, N., GIEZEK, H., WEST, J., SCHNITZER, T. J. (2009). Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced Bone Loss: A 12-Month Randomized, Placebo-Controlled Clinical Trial. The Journal of Rheumatology 36: 1705-1714 [Abstract] [Full Text]  
• Guler-Yuksel, M, Allaart, C F, Goekoop-Ruiterman, Y P M, de Vries-Bouwstra, J K, van Groenendael, J H L M, Mallee, C, de Bois, M H W, Breedveld, F C, Dijkmans, B A C, Lems, W F (2009). Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis. Ann Rheum Dis 68: 330-336 [Abstract] [Full Text]  
• Imazio, M., Brucato, A., Cumetti, D., Brambilla, G., Demichelis, B., Ferro, S., Maestroni, S., Cecchi, E., Belli, R., Palmieri, G., Trinchero, R. (2008). Corticosteroids for Recurrent Pericarditis: High Versus Low Doses: A Nonrandomized Observation. Circulation 118: 667-671 [Abstract] [Full Text]  
• Guler-Yuksel, M, Bijsterbosch, J, Goekoop-Ruiterman, Y P M, de Vries-Bouwstra, J K, Hulsmans, H M J, de Beus, W M, Han, K H, Breedveld, F C, Dijkmans, B A C, Allaart, C F, Lems, W F (2008). Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis. Ann Rheum Dis 67: 823-828 [Abstract] [Full Text]  
• Salvarani, C., Pipitone, N., Boiardi, L., Hunder, G. G (2008). Do we need treatment with tumour necrosis factor blockers for giant cell arteritis?. Ann Rheum Dis 67: 577-579 [Full Text]  
• Tincani, A., Nuzzo, M., Lojacono, A., Cattalini, M., Meini, A. (2007). Review: Contraception in adolescents with systemic lupus erythematosus. Lupus 16: 600-605 [Abstract]  
• Buckland-Wright, J. C., Messent, E. A., Bingham, C. O. III, Ward, R. J., Tonkin, C. (2007). A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients. Rheumatology (Oxford) 46: 257-264 [Abstract] [Full Text]  
• Gaffo, A., Saag, K. G., Curtis, J. R. (2006). Treatment of rheumatoid arthritis. Am J Health Syst Pharm 63: 2451-2465 [Abstract] [Full Text]